Navigation Links
Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA)
Date:9/24/2013

rious addictions."

About Lightlake Therapeutics
Lightlake Therapeutics Inc., a London-based biopharmaceutical company, is using its expertise in opioid antagonists to build a platform of innovative solutions to common addictions and related disorders. The Company holds patents covering the use of intranasal naloxone to treat Binge Eating Disorder ("BED") as well as patents covering addiction to drugs including cocaine, amphetamine, and MDMA. Lightlake is currently focused on advancing its treatment for BED, which has successfully completed Phase II clinical trials, and a Phase II trial is planned for the indication of Bulimia Nervosa. Lightlake is also applying its technology to develop a treatment for managing the complications of opioid drug addiction in collaboration with the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. For more information please visit: http://www.lightlaketherapeutics.com.

Forward Looking Statement
This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue
'/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
2. Moderna Therapeutics Named a "Fierce 15" Biotech Company for 2013
3. Protagonist Therapeutics Expands Series B Financing to $18 Million with Addition of $4 Million from Pharmstandard
4. PTC Therapeutics to Present at European Pediatric Neurology Society Congress
5. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
6. Adheron Therapeutics Names New Senior Leadership
7. Case Report Suggests Microbiome Therapeutics NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
8. Echo Therapeutics Sends Response to Shareholder Letter
9. Convoy Therapeutics to Present at 2013 Rocky Mountain Life Science Investor and Partnering Conference
10. Orexigen Therapeutics Prepares for the Light Study Interim Analysis Based on Direction from Data Monitoring Committee
11. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 EXpressLO LLC, expert provider ... specimen preparation solutions, has been granted patent number 8,789,826 ... manipulation methods incorporating a unique specimen carrier support grid ... the second company patent for EXpressLO LLC awarded to ... , These complementary patents extend EXpressLO’s portfolio of intellectual ...
(Date:7/28/2014)... July 28, 2014 “2014 ... Lubricant Industry” is a professional and in-depth ... market. The report introduces Lubricant basic information, ... chain structure and industry overview. This research ... domestic market as well as global industry ...
(Date:7/28/2014)... 2014 According to ... (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, ... Characterization) - Global Forecasts to 2019" published ... estimated at $896.5 Million in 2014 and ... 2019, growing at a CAGR of 5.9% ...
(Date:7/28/2014)... It’s a hard truth: Nearly half of ... their post-secondary education are failing to obtain a diploma or ... And according to an analysis by The Resume Place ... uninformed choice of college majors, which leads to underemployment, unemployment ... Some 51.7 percent of post-9/11 veterans using GI Bill ...
Breaking Biology Technology:EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 3Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 4Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4
... HONG KONG, July 6 /PRNewswire-Asia/ -- ... direct access to Filligent,s patented anti-,microbial face mask, the ... H1N1 upon contact, was launched at Asia,s leading drugstore,chain, ... Hong,Thai, will be providing the BioMask(TM), on a complimentary ...
... produce only a relatively short extension of survival is a ... addressed by the oncology community, according to a commentary published ... Cancer Institute . Tito Fojo, M.D., Ph.D., of ... National Cancer Institute, in Bethesda, Md., and Christine Grady, Ph.D., ...
... Calif., July 2 Advanced Chemical Transport, ... announced a multi-year partnership with Gilead Sciences Inc., North ... will provide Environmental services - including hazardous Materials disposal, ... onsite waste management support from its corporate headquarters in ...
Cached Biology Technology:High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu 2High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu 3High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu 4High-Tech 'Smart' Face Mask Helps Hong Kong Families Combat Swine Flu 5How much is life worth? The $440 billion question 2
(Date:7/29/2014)... of Ascension Island, one of the world,s largest green ... Writing in the journal Biodiversity and Conservation , ... Government Conservation Department report that the number of green ... increased by more than 500 per cent since records ... are now estimated to be laid on the Island,s ...
(Date:7/29/2014)... Aarhus University researchers have developed an easier method ... strengthen the work involved in diagnosing diseases. , ... provides a strong partnership that can be used ... conjugates which tag proteins with DNA ... sensitive detection and visualisation of biological material. The ...
(Date:7/29/2014)... 23andMe, the leading personal genetics company, has received ... grant totaling $1,367,504 for a two-year project to ... and research engine for genetic discovery. , ... , Refinement of web-based surveys to improve ... , Enhanced infrastructure of survey tools to support ...
Breaking Biology News(10 mins):Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2New method provides researchers with efficient tool for tagging proteins 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3
... report the first identification of a cellular mechanism linked ... water disinfection byproducts. This study, published in Environmental ... adverse health effects, including neurological diseases such as Alzheimer,s. ... give you Alzheimer,s," said Michael Plewa, lead scientist and ...
... 40-year search for a gene that causes some one-celled ... found in others that produce deadly red tides, has ... by Thomas E. DeCoursey, PhD, professor of biophysics and ... discovered in a tiny marine organism called a dinoflagellate ...
... -- FASEB MARC Program has announced the travel award recipients ... in Atlanta, Georgia from Oct. 20-23, 2011. These awards ... succeed in graduate study and to prepare them for success ... The FASEB MARC Program is funded by a grant from ...
Cached Biology News:Research links water disinfection byproducts to adverse health effects 2Research links water disinfection byproducts to adverse health effects 3Discovery illuminates elusive proton channel gene in dinoflagellates 2Discovery illuminates elusive proton channel gene in dinoflagellates 3
Request Info...
Request Info...
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Biology Products: